E-cadherin expression on multiple myeloma cells activates tumor-promoting properties in plasmacytoid DCs

  • 0Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.

|

|

Summary

This summary is machine-generated.

Multiple myeloma tumors reprogram plasmacytoid dendritic cells (pDCs) to promote cancer growth. Blocking E-cadherin interactions or depleting pDCs may offer new therapeutic strategies for multiple myeloma.

Area Of Science

  • Immunology
  • Oncology
  • Molecular Biology

Background

  • Plasmacytoid dendritic cells (pDCs) are crucial for antiviral immunity via type-1 interferon (IFN) production.
  • Emerging evidence indicates pDCs can promote tumor growth and immune suppression in cancers like ovarian cancer and multiple myeloma (MM).
  • The mechanisms by which pDCs acquire tumor-promoting properties remain largely unknown.

Purpose Of The Study

  • To elucidate the molecular mechanisms by which multiple myeloma cells influence pDCs.
  • To investigate the role of E-cadherin in mediating pDC-myeloma cell interactions.
  • To identify potential therapeutic targets for multiple myeloma based on pDC modulation.

Main Methods

  • In vitro co-culture systems of human pDCs and myeloma cells.
  • Analysis of E-cadherin-mediated signaling pathways, including TNFAIP3 and TLR9.
  • In vivo studies using the Vk*MYC myeloma mouse model with pDC depletion.
  • Correlation analysis of IFNAR1 expression and patient survival in multiple myeloma.

Main Results

  • Direct contact with myeloma cells, mediated by E-cadherin homophilic interaction, suppressed pDC IFN-α production.
  • E-cadherin signaling activated TNFAIP3, leading to TLR9 ubiquitination, degradation, and subsequent inhibition of IFN-α.
  • pDC depletion in vivo resulted in significant tumor regression and improved survival in a mouse model of multiple myeloma.
  • Lower IFN-α levels were observed in the bone marrow of multiple myeloma patients compared to healthy individuals.
  • Higher IFNAR1 expression correlated positively with overall survival in multiple myeloma patients.

Conclusions

  • Multiple myeloma tumors educate pDCs within the tumor microenvironment to adopt immunosuppressive functions.
  • The E-cadherin/TNFAIP3/TLR9 axis is a key mechanism for myeloma-induced pDC reprogramming.
  • Targeting pDC-myeloma cell interactions or modulating pDC function presents a promising therapeutic avenue for multiple myeloma.

Related Concept Videos

Regulation of Expression Occurs at Multiple Steps 02:24

26.4K

Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...

Regulation of Expression Occurs at Multiple Steps 02:24

4.0K
Structure of Cadherins 01:25

4.9K

The cadherins were one of the first cell adhesion molecules discovered; the term “cadherins”   is based on their calcium-dependent adhering properties. The first cadherins discovered on the epithelial, neuronal, and placental cells were named E-cadherin, P-cadherin, and N-cadherin, respectively. These classical cadherins share sequence and structural similarities. Other cadherins, including those involved in cell signaling, are grouped into non-classical cadherins. This...

Regulation of Expression at Multiple Steps 01:23

1.4K

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...

Cadherins in Tissue Organization 01:19

4.2K

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...

The Eukaryotic Promoter Region 02:40

18.8K

The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences.  The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...